REDHILL BIOPHARMA LTD. UNDERWRITING AND PLACEMENT AGENCY AGREEMENTUnderwriting and Placement Agency Agreement • December 23rd, 2016 • RedHill Biopharma Ltd. • Pharmaceutical preparations • New York
OBSEVA SA Underwriting and Placement Agency AgreementUnderwriting and Placement Agency Agreement • September 8th, 2020 • ObsEva SA • Pharmaceutical preparations • New York
ObsEva SA, a société anonyme organized under the laws of Switzerland (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom H.C. Wainwright & Co., LLC (“Wainwright”) is acting as representative, (i) an aggregate of (a) 5,490,000 common shares (the “Underwritten Shares”), par value CHF 1/13 per share, of the Company (the “Common Shares”) and (b) 958,240 pre-funded warrants to purchase 958,240 Common Shares at an exercise price of CHF 1/13 per share substantially in the form set forth on Exhibit D (the “Pre-Funded Warrants”) and (ii) warrants to purchase up to 6,448,240 Common Shares at an exercise price of $3.43 per share substantially in the form set forth on Exhibit E hereto (the “Underwritten Warrants” and, together with the Underwritten Shares and the Pre-Funded Warrants, the “Underwritten Securities”). Simultaneously with the purchase and sale to the Underwriters of the Underwritten Securities, the Company
